Novavax Stock: Buy, Sell, or Hold in 2023?

06:00am, Thursday, 24'th Nov 2022
The shares are heading for almost a 90% loss this year.

Novavax (NVAX) Cancels COVID Jab Supply Deal With GAVI

05:35pm, Wednesday, 23'rd Nov 2022 Zacks Investment Research
Novavax (NVAX) claims that GAVI's failure to procure its COVID vaccine doses is a reason to terminate the supply agreement. GAVI denies the company's claims and a legal battle is likely to follow.
Novavax (NVAX) claims that GAVI's failure to procure its COVID vaccine doses is a reason to terminate the supply agreement. GAVI denies the company's claims and a legal battle is likely to follow.
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session. Perfect Corp. (NYSE: PERF) shares tum

Why Shares of Novavax Are Down Tuesday

08:46pm, Tuesday, 22'nd Nov 2022 The Motley Fool
A disagreement over a contract sent the stock tumbling.

Why Shares of Novavax Are Down Tuesday

03:46pm, Tuesday, 22'nd Nov 2022
A disagreement over a contract sent the stock tumbling.
Reuters China To Reportedly Impose Over $1B Fine On Jack Ma's Ant Group Ending 2-Year Long Regulatory Overhaul Ending Jack Ma's Ant Group's two-year-long regulatory feud, Chinese authorities will
Despite a strong rally seen in today's market, not all stocks are participating in the fun. One company that's currently sitting out this rally is vaccine maker Novavax (NASDAQ: NVAX ).
These beaten-down innovators have industry-changing potential.
These beaten-down innovators have industry-changing potential.
Dr. Scott Gottlieb, former FDA commissioner, joins "Squawk Box" to discuss progress on developing and distributing vaccines to fight the spread of coronavirus.
Billionaire Bill Gates said Johnson & Johnson's and Novavax's Covid-19 vaccines will still be essential tools against new, emerging variants of the virus.
Novavax is currently conducting three efficacy trials for its Covid-19 vaccines. The vaccine is 96 percent effective against the Wuhan Covid strain and 86 percent effective against the U.K. strain.
Novavax Inc. (NASDAQ:NVAX) just received expanded authorization in Canada for its Coivd-19 booster.
Shares of Novavax Inc. NVAX, -3.17% were up 2.4% in premarket trading on Friday after the company said its COVID-19 booster was authorized for adults in Canada who were previously immunized with Novav
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE